34852451|t|Clinical and Molecular Characteristics of PRKACA L206R Mutant Cortisol-Producing Adenomas in Korean Patients.
34852451|a|BACKGROUND: An activating mutation (c.617A>C/p.Lys206Arg, L206R) in protein kinase cAMP-activated catalytic subunit alpha (PRKACA) has been reported in 35% to 65% of cases of cortisol-producing adenomas (CPAs). We aimed to compare the clinical characteristics and transcriptome analysis between PRKACA L206R mutants and wild-type CPAs in Korea. METHODS: We included 57 subjects with CPAs who underwent adrenalectomy at Seoul National University Hospital. Sanger sequencing for PRKACA was conducted in 57 CPA tumor tissues. RNA sequencing was performed in 13 fresh-frozen tumor tissues. RESULTS: The prevalence of the PRKACA L206R mutation was 51% (29/57). The mean age of the study subjects was 42+-12 years, and 87.7% (50/57) of the patients were female. Subjects with PRKACA L206R mutant CPAs showed smaller adenoma size (3.3+-0.7 cm vs. 3.8+-1.2 cm, P=0.059) and lower dehydroepiandrosterone sulfate levels (218+-180 ng/mL vs. 1,511+-3,307 ng/mL, P=0.001) than those with PRKACA wild-type CPAs. Transcriptome profiling identified 244 differentially expressed genes (DEGs) between PRKACA L206R mutant (n=8) and wild-type CPAs (n=5), including five upregulated and 239 downregulated genes in PRKACA L206R mutant CPAs ( fold change  >=2, P<0.05). Among the upstream regulators of DEGs, CTNNB1 was the most significant transcription regulator. In several pathway analyses, the Wnt signaling pathway was downregulated and the steroid biosynthesis pathway was upregulated in PRKACA mutants. Protein-protein interaction analysis also showed that PRKACA downregulates Wnt signaling and upregulates steroid biosynthesis. CONCLUSION: The PRKACA L206R mutation in CPAs causes high hormonal activity with a limited proliferative capacity, as supported by transcriptome profiling.
34852451	42	48	PRKACA	Gene	5566
34852451	49	54	L206R	ProteinMutation	tmVar:p|SUB|L|206|R;HGVS:p.L206R;VariantGroup:0;CorrespondingGene:5566;RS#:386352352(Expired);CorrespondingSpecies:9606;CA#:215006
34852451	62	89	Cortisol-Producing Adenomas	Disease	MESH:D049913
34852451	100	108	Patients	Species	9606
34852451	146	154	c.617A>C	DNAMutation	tmVar:c|SUB|A|617|C;HGVS:c.617A>C;VariantGroup:1;CorrespondingGene:5566;CorrespondingSpecies:9606
34852451	155	166	p.Lys206Arg	ProteinMutation	tmVar:p|SUB|K|206|R;HGVS:p.K206R;VariantGroup:0;RS#:386352352(Expired)
34852451	168	173	L206R	ProteinMutation	tmVar:p|SUB|L|206|R;HGVS:p.L206R;VariantGroup:0;CorrespondingGene:5566;RS#:386352352(Expired);CorrespondingSpecies:9606;CA#:215006
34852451	178	231	protein kinase cAMP-activated catalytic subunit alpha	Gene	5566
34852451	233	239	PRKACA	Gene	5566
34852451	285	312	cortisol-producing adenomas	Disease	MESH:D049913
34852451	314	318	CPAs	Disease	MESH:D049913
34852451	405	411	PRKACA	Gene	5566
34852451	412	417	L206R	ProteinMutation	tmVar:p|SUB|L|206|R;HGVS:p.L206R;VariantGroup:0;CorrespondingGene:5566;RS#:386352352(Expired);CorrespondingSpecies:9606;CA#:215006
34852451	440	444	CPAs	Disease	MESH:D049913
34852451	493	497	CPAs	Disease	MESH:D049913
34852451	587	593	PRKACA	Gene	5566
34852451	614	623	CPA tumor	Disease	MESH:C537786
34852451	681	686	tumor	Disease	MESH:D009369
34852451	727	733	PRKACA	Gene	5566
34852451	734	739	L206R	ProteinMutation	tmVar:p|SUB|L|206|R;HGVS:p.L206R;VariantGroup:0;CorrespondingGene:5566;RS#:386352352(Expired);CorrespondingSpecies:9606;CA#:215006
34852451	844	852	patients	Species	9606
34852451	880	886	PRKACA	Gene	5566
34852451	887	892	L206R	ProteinMutation	tmVar:p|SUB|L|206|R;HGVS:p.L206R;VariantGroup:0;CorrespondingGene:5566;RS#:386352352(Expired);CorrespondingSpecies:9606;CA#:215006
34852451	900	904	CPAs	Disease	MESH:D049913
34852451	920	927	adenoma	Disease	MESH:D000236
34852451	982	1012	dehydroepiandrosterone sulfate	Chemical	MESH:D019314
34852451	1085	1091	PRKACA	Gene	5566
34852451	1102	1106	CPAs	Disease	MESH:D049913
34852451	1193	1199	PRKACA	Gene	5566
34852451	1200	1205	L206R	ProteinMutation	tmVar:p|SUB|L|206|R;HGVS:p.L206R;VariantGroup:0;CorrespondingGene:5566;RS#:386352352(Expired);CorrespondingSpecies:9606;CA#:215006
34852451	1233	1237	CPAs	Disease	MESH:D049913
34852451	1303	1309	PRKACA	Gene	5566
34852451	1310	1315	L206R	ProteinMutation	tmVar:p|SUB|L|206|R;HGVS:p.L206R;VariantGroup:0;CorrespondingGene:5566;RS#:386352352(Expired);CorrespondingSpecies:9606;CA#:215006
34852451	1323	1327	CPAs	Disease	MESH:D049913
34852451	1396	1402	CTNNB1	Gene	1499
34852451	1534	1541	steroid	Chemical	MESH:D013256
34852451	1582	1588	PRKACA	Gene	5566
34852451	1652	1658	PRKACA	Gene	5566
34852451	1703	1710	steroid	Chemical	MESH:D013256
34852451	1741	1747	PRKACA	Gene	5566
34852451	1748	1753	L206R	ProteinMutation	tmVar:p|SUB|L|206|R;HGVS:p.L206R;VariantGroup:0;CorrespondingGene:5566;RS#:386352352(Expired);CorrespondingSpecies:9606;CA#:215006
34852451	1766	1770	CPAs	Disease	MESH:D049913
34852451	Association	MESH:D000236	RS#:386352352(Expired);HGVS:p.L206R;CorrespondingGene:5566
34852451	Association	MESH:D049913	RS#:386352352(Expired);HGVS:p.L206R;CorrespondingGene:5566
34852451	Negative_Correlation	MESH:D019314	RS#:386352352(Expired);HGVS:p.L206R;CorrespondingGene:5566
34852451	Association	HGVS:c.617A>C;CorrespondingGene:5566	MESH:D049913
34852451	Negative_Correlation	MESH:D019314	MESH:D049913
34852451	Association	MESH:D049913	RS#:386352352(Expired);HGVS:p.K206R
34852451	Association	MESH:D049913	5566
34852451	Association	MESH:D019314	5566
34852451	Association	MESH:D049913	1499
34852451	Association	MESH:D000236	5566
34852451	Association	MESH:D000236	5566
34852451	Association	MESH:D049913	5566

